Kumar Dhanasekharan
Technik-/Wissenschafts-/F&E-Leiter bei RENOVACOR, INC.
Aktive Positionen von Kumar Dhanasekharan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RENOVACOR, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.10.2021 | - |
Karriereverlauf von Kumar Dhanasekharan
Ehemalige bekannte Positionen von Kumar Dhanasekharan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Corporate Officer/Principal | - | - |
Ausbildung von Kumar Dhanasekharan
| Rutgers University, Camden | Doctorate Degree |
| Indian Institute of Technology Madras | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Indien | 2 |
Operativ
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
- Börse
- Insiders
- Kumar Dhanasekharan
- Erfahrung
